785 related articles for article (PubMed ID: 28052012)
1. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
2. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
3. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells.
Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ
J Virol; 2020 May; 94(10):. PubMed ID: 32102884
[TBL] [Abstract][Full Text] [Related]
4. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.
Tsai MH; Raykova A; Klinke O; Bernhardt K; Gärtner K; Leung CS; Geletneky K; Sertel S; Münz C; Feederle R; Delecluse HJ
Cell Rep; 2013 Oct; 5(2):458-70. PubMed ID: 24120866
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production.
Li Z; Tsai MH; Shumilov A; Baccianti F; Tsao SW; Poirey R; Delecluse HJ
Nat Microbiol; 2019 Dec; 4(12):2475-2486. PubMed ID: 31501540
[TBL] [Abstract][Full Text] [Related]
9. A single nucleotide polymorphism in the BART promoter region of Epstein-Barr virus isolated from nasopharyngeal cancer cells.
Kim H; Burassakarn A; Kang Y; Iizasa H; Yoshiyama H
Biochem Biophys Res Commun; 2019 Dec; 520(2):373-378. PubMed ID: 31606205
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.
Lin X; Tsai MH; Shumilov A; Poirey R; Bannert H; Middeldorp JM; Feederle R; Delecluse HJ
PLoS Pathog; 2015 Dec; 11(12):e1005344. PubMed ID: 26694854
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
[TBL] [Abstract][Full Text] [Related]
12. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
[TBL] [Abstract][Full Text] [Related]
13. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
[TBL] [Abstract][Full Text] [Related]
14. Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells.
Müller Coan BG; Cesarman E; Acencio ML; Elgui de Oliveira D
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205397
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.
Marquitz AR; Mathur A; Chugh PE; Dittmer DP; Raab-Traub N
J Virol; 2014 Jan; 88(2):1389-93. PubMed ID: 24227849
[TBL] [Abstract][Full Text] [Related]
16. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cellular expression in EBV infected epithelial cell lines and tumors.
Edwards RH; Dekroon R; Raab-Traub N
PLoS Pathog; 2019 Oct; 15(10):e1008071. PubMed ID: 31584998
[TBL] [Abstract][Full Text] [Related]
19. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
Front Immunol; 2020; 11():367. PubMed ID: 32194570
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
